MX2020007927A - Uso de carbonato de calcio funcionalizado como ingrediente activo. - Google Patents

Uso de carbonato de calcio funcionalizado como ingrediente activo.

Info

Publication number
MX2020007927A
MX2020007927A MX2020007927A MX2020007927A MX2020007927A MX 2020007927 A MX2020007927 A MX 2020007927A MX 2020007927 A MX2020007927 A MX 2020007927A MX 2020007927 A MX2020007927 A MX 2020007927A MX 2020007927 A MX2020007927 A MX 2020007927A
Authority
MX
Mexico
Prior art keywords
active ingredient
calcium carbonate
functionalized calcium
functionalized
dosage form
Prior art date
Application number
MX2020007927A
Other languages
English (en)
Inventor
Tanja Budde
Lalit Sharma
Original Assignee
Omya Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omya Int Ag filed Critical Omya Int Ag
Publication of MX2020007927A publication Critical patent/MX2020007927A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/24—Compounds of alkaline earth metals, e.g. magnesium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/1578—Calcium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Pediatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)

Abstract

La presente invención está relacionada con una formulación que comprende carbonato de calcio funcionalizado que sirve como ingrediente activo. La invención además está relacionada con el uso de una formulación como suplemento nutricional o como un medicamento y con el uso de carbonato de calcio funcionalizado como ingrediente activo, preferentemente en el campo de la fortificación con calcio y en el tratamiento de la deficiencia de calcio.
MX2020007927A 2018-01-31 2019-01-25 Uso de carbonato de calcio funcionalizado como ingrediente activo. MX2020007927A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18154469.3A EP3520798A1 (en) 2018-01-31 2018-01-31 Use of functionalized calcium carbonate as active ingredient
PCT/EP2019/051839 WO2019149628A1 (en) 2018-01-31 2019-01-25 Use of functionalized calcium carbonate as active ingredient

Publications (1)

Publication Number Publication Date
MX2020007927A true MX2020007927A (es) 2020-09-03

Family

ID=61231045

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020007927A MX2020007927A (es) 2018-01-31 2019-01-25 Uso de carbonato de calcio funcionalizado como ingrediente activo.

Country Status (18)

Country Link
US (1) US20210379100A1 (es)
EP (2) EP3520798A1 (es)
JP (1) JP2021512058A (es)
CN (1) CN111655235A (es)
AR (1) AR114352A1 (es)
AU (1) AU2019214818A1 (es)
BR (1) BR112020010926A2 (es)
CA (1) CA3083862A1 (es)
CL (1) CL2020001926A1 (es)
CO (1) CO2020007892A2 (es)
ES (1) ES3040784T3 (es)
IL (1) IL276069A (es)
MX (1) MX2020007927A (es)
PH (1) PH12020500606A1 (es)
PL (1) PL3746045T3 (es)
RU (1) RU2020128587A (es)
SG (1) SG11202005012UA (es)
WO (1) WO2019149628A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR123009A1 (es) 2020-07-20 2022-10-19 Omya Int Ag Agente estabilizante para composición probiótica

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2166797A (en) 1938-08-17 1939-07-18 Gen Mills Inc Process of fortifying cereal products with minerals
CA1256739A (en) 1985-03-19 1989-07-04 Michael B. Zemel Calcium fortified soy milk
JP2923181B2 (ja) * 1993-09-20 1999-07-26 フジックス株式会社 高濃度のカルシウムを含有する水溶性粉末およびその製造方法
GB9825033D0 (en) * 1998-11-13 1999-01-13 Nycomed Pharma As Process
FR2787802B1 (fr) * 1998-12-24 2001-02-02 Pluss Stauffer Ag Nouvelle charge ou pigment ou mineral traite pour papier, notamment pigment contenant du caco3 naturel, son procede de fabrication, compositions les contenant, et leurs applications
US20020044974A1 (en) 2000-09-07 2002-04-18 Malcolm Alexander R. Granular calcium carbonate for use as a dietary supplement and/or antacid
AU2002331013A1 (en) 2001-08-09 2003-02-24 Rhodia Inc. Calcium dietary supplement
FR2852600B1 (fr) 2003-03-18 2005-06-10 Nouveau pigment mineral contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
FR2871474B1 (fr) 2004-06-11 2006-09-15 Omya Development Ag Nouveau pigment mineral sec contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
US7829127B2 (en) 2005-03-25 2010-11-09 The Hershey Company Fortification of syrup with calcium and other minerals and vitamins
WO2007134158A2 (en) 2006-05-12 2007-11-22 Drugtech Corporation Granules comprising calcium carbonate, a binder and a porosity increasing agent, processes of manufacturing, use in therapy
US9138414B1 (en) * 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
JP4580034B2 (ja) * 2007-07-13 2010-11-10 株式会社メニコン カルシウムイオン徐放剤
ATE480597T1 (de) 2007-12-12 2010-09-15 Omya Development Ag Verfahren zur herstellung von oberflächenreaktives fällungskalziumkarbonat
EP2264108B1 (en) * 2009-06-15 2012-02-15 Omya Development AG Process to prepare a surface-reacted calcium carbonate implementing a weak acid
PT2264109E (pt) 2009-06-15 2012-05-09 Omya Development Ag Processo de preparação de carbonato de cálcio com superfície tratada por reacção e sua utilização
SI2371766T1 (sl) 2010-04-01 2013-07-31 Omya Development Ag Postopek za pridobivanje oborine kalcijevega karbonata
PT2447213E (pt) 2010-10-26 2015-08-20 Omya Int Ag Produção de carbonato de cálcio de alta pureza
DK2524898T3 (en) 2011-05-16 2015-12-14 Omya Int Ag Process for the preparation of precipitated calcium carbonate from fiber pulp mill waste
TWI625129B (zh) * 2011-11-10 2018-06-01 歐米亞國際公司 新穎的經塗布控釋活性劑載體
CA2865647C (en) 2012-03-23 2017-04-18 Omya International Ag Process for preparing scalenohedral precipitated calcium carbonate
DK2840065T3 (da) 2013-08-20 2017-02-20 Omya Int Ag Fremgangsmåde til fremstilling af præcipiteret calciumcarbonat
GB2522665A (en) * 2014-01-31 2015-08-05 Nec Corp Communication system
EP2921173A1 (en) * 2014-03-21 2015-09-23 Omya International AG Surface-reacted calcium carbonate for desensitizing teeth
ES2667337T3 (es) * 2014-09-22 2018-05-10 Omya International Ag Carbonato de calcio tratado mediante reacción superficial para su uso como agente antiapelmazante
EP3034070A1 (en) * 2014-12-18 2016-06-22 Omya International AG Method for the production of a pharmaceutical delivery system
EP3260115A1 (en) * 2016-06-21 2017-12-27 Omya International AG Method for the production of a dosage form
EP3269361A1 (en) * 2016-07-14 2018-01-17 Omya International AG Dosage form

Also Published As

Publication number Publication date
PL3746045T3 (pl) 2025-10-06
PH12020500606A1 (en) 2021-06-07
AU2019214818A1 (en) 2020-06-18
ES3040784T3 (en) 2025-11-04
RU2020128587A (ru) 2022-02-28
CO2020007892A2 (es) 2020-08-21
JP2021512058A (ja) 2021-05-13
CL2020001926A1 (es) 2020-12-04
RU2020128587A3 (es) 2022-02-28
US20210379100A1 (en) 2021-12-09
IL276069A (en) 2020-08-31
CN111655235A (zh) 2020-09-11
EP3746045C0 (en) 2025-08-13
SG11202005012UA (en) 2020-06-29
EP3520798A1 (en) 2019-08-07
EP3746045B1 (en) 2025-08-13
WO2019149628A1 (en) 2019-08-08
BR112020010926A2 (pt) 2020-11-17
AR114352A1 (es) 2020-08-26
KR20200116150A (ko) 2020-10-08
CA3083862A1 (en) 2019-08-08
EP3746045A1 (en) 2020-12-09

Similar Documents

Publication Publication Date Title
EP4424368A3 (en) Compositions comprising an urolithin compound
WO2016190683A8 (ko) 길경 추출물을 함유하는 근육 질환 예방 및 치료용 또는 근 기능 개선용 조성물
MX379201B (es) Derivados de 3-(carboxietil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano.
ZA201805358B (en) 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
EP4272832A3 (en) Antimicrobial compounds, compositions, and uses thereof
TN2016000498A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine.
RU2009134848A (ru) Транквилизатор и функциональный продукт питания
PH12020500606A1 (en) Use of functionalized calcium carbonate as active ingredient
ZA201906153B (en) Pharmaceutical compositions for combination therapy
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
ZA201905212B (en) Rescue treatment of post operative nausea and vomiting
MX2022013541A (es) Composiciones de acido gamma-poliglutamico y zinc.
PH12017500743A1 (en) Tau protein production accelerator, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by tau protein deficiency
WO2019022602A8 (en) Pharmaceutical composition for use in the treatment or prevention of vitamin deficiency and mineral deficiency in patients who have been subjected to gastric sleeve surgery
WO2016027225A8 (en) A composition having a muscle-relaxant and anti-inflammatory activity
EP4483870A3 (en) Aqueous retinol formulations
PL421363A1 (pl) Zastosowanie derenia właściwego Cornus mas L. lub jego tkanek lub ich wytworów, zwłaszcza ekstraktu z owoców
WO2015126151A3 (ko) 신곡 추출물을 포함하는 상처 치료용 조성물
MX2023005681A (es) Composicion farmaceutica para el tratamiento contra el dolor agudo y cronico, que contiene polmacoxib y tramadol.
WO2019059550A3 (ko) 체지방 감소 보조제 및 베타글루칸을 유효성분으로 하는 비만 예방 또는 치료용 조성물
GEU20151862Y (en) Biologically active confectionery product
TH168474A (th) องค์ประกอบที่กระตุ้นการสร้างน้ำนมที่มีพื้นฐานมาจากฟอสฟาติดิลเซอรีน
NZ727233A (en) Stabilized oxymetazoline formulations and their uses
PL414044A1 (pl) Plaster zawierający substancje bakteriobójcze i/lub bakteriostatyczne i/lub wirusobójcze i/lub\ grzybobójcze stosowane miejscowo jako innowacyjna forma aplikacji w leczeniu urazów ciała
MY192867A (en) Orally disintigrating tablet comprising moringa oleifera leaves powder